For example, PIM2 modulates mTORC1 activity through phosphorylation of TSC2 in other cancers [21], while PIM1 phosphorylates PRAS40 thereby relieving its inhibitory effects on mTORC1 with a subsequent increase in mTORC1 activity [22]. Here, AKT1S1 is linked to cancer.